• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Prostaglandins and related compounds
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Eicosanoids Prostaglandins and related compounds

Comprehensive Overview of 8-epi PGF2alpha-d4 (CAS No. 211105-40-7)

8-epi PGF2alpha-d4 (CAS No. 211105-40-7) is a deuterated analog of the prostaglandin 8-epi PGF2alpha, a compound that has garnered significant attention in the fields of biochemistry and pharmacology due to its role in various physiological processes. This deuterated form is particularly valuable in research settings for its enhanced stability and reduced metabolic degradation, making it an ideal tool for studying the biological activities and mechanisms of action of prostaglandins.

Prostaglandins are a group of lipid compounds derived from fatty acids, primarily arachidonic acid, through the action of cyclooxygenase enzymes. They play crucial roles in a wide range of physiological and pathological processes, including inflammation, pain, fever, and the regulation of smooth muscle contraction. 8-epi PGF2alpha, specifically, is an isoprostane formed through the non-enzymatic peroxidation of arachidonic acid and is known to be a marker of oxidative stress and lipid peroxidation.

The deuterated form, 8-epi PGF2alpha-d4, is synthesized by incorporating deuterium atoms at specific positions in the molecule. This modification significantly alters the kinetic properties of the compound, making it more resistant to metabolic breakdown. As a result, 8-epi PGF2alpha-d4 can be used as a stable internal standard in mass spectrometry-based assays, enhancing the accuracy and reliability of quantitative analyses.

In recent years, research on 8-epi PGF2alpha-d4 has expanded to include its applications in various fields. One notable area of interest is its use as a biomarker for oxidative stress. Oxidative stress is implicated in numerous diseases, including cardiovascular disorders, neurodegenerative diseases, and cancer. By measuring levels of 8-epi PGF2alpha-d4, researchers can gain insights into the extent of oxidative damage in biological samples, which can inform diagnostic and therapeutic strategies.

Clinical studies have also explored the potential therapeutic applications of 8-epi PGF2alpha-d4. For instance, its ability to modulate smooth muscle contraction has been investigated in the context of treating conditions such as asthma and hypertension. Additionally, its role in inflammation and pain management has been studied, with promising results suggesting that it may have anti-inflammatory properties.

The use of deuterated compounds like 8-epi PGF2alpha-d4 in drug development is another area of active research. Deuteration can improve the pharmacokinetic properties of drugs by increasing their half-life and reducing their toxicity. This makes them attractive candidates for developing more effective and safer medications. Several pharmaceutical companies are currently investigating the potential of deuterated analogs in their drug pipelines.

In conclusion, 8-epi PGF2alpha-d4 (CAS No. 211105-40-7) is a valuable tool in both research and clinical settings due to its enhanced stability and unique properties. Its applications span from biomarker analysis to drug development, making it a compound of significant interest for scientists and clinicians alike. As research continues to uncover new insights into its mechanisms and potential uses, the importance of 8-epi PGF2alpha-d4 is likely to grow even further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)